Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ergoferon in Viral Intestinal Infections in Children
NCT03039699Phase 4Completed
- Sponsor
- Materia Medica Holding
- Start
- Jun 2016
- Primary completion
- Jun 2019
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 2
01
Overview
A Phase 4 trial of Ergoferon in viral gastroenteritis, sponsored by Materia Medica Holding. Started Jun 2016; status: completed.
02
Drugs
Ergoferon
03
Conditions
viral gastroenteritis
Beyond the preview
Go deeper on NCT03039699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03039699.